Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Inhaled Insulin (Exubera) vs Subcutaneous Insulin in Type 1 Diabetes
NCT00424437Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 1999
- Modality
- Biologic
- Countries
- 2
01
Overview
A Phase 3 trial of insulin human in type 1 diabetes mellitus (T1D), sponsored by Pfizer. Started Sep 1999; status: completed.
02
Drugs
insulin human
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00424437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424437.